Kodak shows miniPACS for echo at AHA meeting
Kodak shows miniPACS for echo at AHA meetingEastman Kodak displayed a new echocardiography miniPACS workstation as a work-in-progress at last month's American Heart Association meeting in Dallas. The as-yet-unnamed system is designed to provide
Kodak shows miniPACS for echo at AHA meeting
Eastman Kodak displayed a new echocardiography miniPACS workstation as a work-in-progress at last month's American Heart Association meeting in Dallas. The as-yet-unnamed system is designed to provide echocardiography labs with an integrated image and information management system, according to Dennis Schubert, director of the worldwide echocardiography business for the Rochester, NY, company.
The new workstation is based on the Windows NT operating system and features support for the DICOM 3.0 standard throughout, Schubert said. These properties differentiate the workstation from Access, Kodak's radiology ultrasound miniPACS workstation, which is based on the OS/2 operating system and was developed before DICOM 3.0 was ratified. The new echo workstation also features reporting and database software developed in cooperation with the Mayo Clinic in Rochester.
Kodak hopes to have the workstation in beta testing in the second quarter of 1999, Schubert said. Eventually, Kodak could replace Access with the new echo miniPACS, which would probably be more attractive to potential purchasers due to its NT platform. Kodak might also expand the workstation to support other cardiac imaging modalities.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
